JP

Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

Hong Kong (China) *

Republic of Korea *

gated page adc in neuro hero

Whitepaper

Advancing cancer treatment: The promise of ADCs in oncology and neuro-oncology

Antibody-drug conjugates (ADCs) are reshaping cancer therapy by combining targeted delivery with potent cytotoxic effects. This white paper explores their evolving role in oncology and neuro-oncology.
Inside, you'll find dedicated sections covering:

A clear explanation of how ADCs work
Detailed applications in both oncology and neuro-oncology
Key technological innovations in antibody design, linker chemistry, and payload development
An overview of manufacturing processes and quality control considerations

To view the full content please answer a few questions

営業担当者から連絡を受けることに同意します。

お名前（名）

お名前（姓）

国

メールアドレス

会社名

郵便番号

勤務先電話番号

職種

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Download Resource

Advancing cancer treatment: The promise of ADCs in oncology and neuro-oncology

Download Whitepaper